Dalcetrapib

DB12181InvestigationalSmall molecule

Dalcetrapib is under investigation for the treatment of Acute Coronary Syndrome.

Mechanism: Pharmacologically active on Cholesteryl ester transfer protein
Curator reviewed
Formula / weight: C₂₃H₃₅NO₂S · 389.6 g/mol (avg)
Code names: JTT-705 · RO-4607381

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyYZQLWPMZQVHJED-UHFFFAOYSA-NSMILESCCC(CC)CC1(CCCCC1)C(=O)NC1=CC=CC=C1SC(=O)C(C)C

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

10Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dalcetrapib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.